About Us

Mission & Vision

Based On The World’s first DNA Aptamer Patent, Becoming A Global Therapeutics and Healthcare Market Leader

  • DNA R&D Innovator

    Started business with R&D for the innovative DNA-based AD/PD medicines, and expand the business to healthcare and cosmeceutical markets

  • Global ingredient IPs

    World’s first perfect antioxidants DNA Aptamer, Aptamin® patents rights owner (30+)

  • Game Changer

    Go to global, and suggest new industrial standards with DNA Aptamer

Business Scope

Company History

  • 2020 ~ 2018
  • 2017 ~ 2014
  • 2020
    Aptamin®C GRAS Notification (FDA, US)
    Aptamin®C additional patent registration (US, Korea)
  • 2019
    Developed Aptamin®C ingredient for skincare
    Launched Aptamin®C finished cosmetic goods
    Posted an study results of Aptamin®C skincare on Journal of Cosmetic Dermatology
    Venture Business Certification
    TIDES, Poster Presentation
    AMWC, Poster Presentation
    InCosmetics Global, CosmeTech
    Started co-research with Kyunghee University, Chungang University, Sookmyung Women’s University
  • 2018
    Developed Aptamin®H, K, G
    Publish Aptamin®C, Aptamers
    Aptamin®C Korea Cosmetic Association Registration
    IFSCC, Poster Presentation
    IPO, Selection of an organizing company(KB securities)
  • 2017
    Aptamin®C ICID register
    Co-developed Aptamin® with Hanyang Universigy
  • 2016
    Developed Aptamin®C
    Gold prizes awarded in <Huzel Open Innovation>
  • 2015
    Developed microneedle patch type of early diagnosis system
  • 2014
    Developed contact-lens type of early diagnosis system

Business Roadmap

Entering the global healthcare market with the start of commercializing the first DNA Aptamer in worldwide

IP(Intellectual Property)

Intellectual Property Status

1 1 2 1 1 4 2 2 PCT14 Processing
Area Applied PCT Registered Total
Aptamin® 5 8 4 17
Therapeutics 2 2 4
Early Diagnosis 1 3 4
Other 2 1 3
Total 10 14 4 28
  • 5
  • 7
  • 4

Osong R&D center

Build DNA R&D Center at O-song Hyper Medical Multiplex in 2021 (Total site area: 8,241.8 m²)


  • Key members
  • Advisory
  • Co-CEO

    Wayne Lee

    ITE Co., V.President
    BizInfra Co., CEO
    IFS Korea, CEO
    IBM Korea
    Hanyang University

  • Co-CEO & CTO

    Michael Kim Ph.D.

    CTO, Dongkook Pharmaceutical Co., Ltd.
    CTO, Dong-A Pharmaceutical Co., Ltd.
    Ph.D. in Pharmacy, Chung-Ang Univ.

  • CSO

    Eric Sohn

    C.P.M / 6Sigma MBB
    G. Manager, IMaketKorea
    Samsung Fire & Marine Insurance

  • Head of Healthcare Dept.

    Lloyd Park

    G. Manager, IMaketKorea
    Sales, Sindoh Ricoh

  • R&D Advisor

    Yoonsung Kim, M.D., Ph.D.

    Rutgers University Medical School
    Weill Cornell Medicine
    Ph.D. in Medical School, Cornell Univ.

  • R&D Advisor

    Yeongjeong Kim, Ph.D.

    Dept. of Nursing Science,
    Kyunghee University
    Post-doc. Fellowship, Weill Medical School, Cornell Univ.
    Ph.D, Kyunghee University

  • R&D Advisor

    Taebeom Ahn, M.D., Ph.D.

    Medical Center, Kyunghee University
    Fellowship Research, Neuroscience Research Center, Mayo Clinic
    M.D., Ph.D., Neurology, Seoul National University

  • R&D Advisor

    Cheungseog Park, M.D., Ph.D.

    Medical Center, Kyunghee University
    M.D., Ph.D., Kyunghee University

  • Nonexecutive Director

    Jaeryun Kwon

    CEO, Winner Study
    CEO, Korea M.N.A.
    CEO, Korea Corporate Investment Co., Ltd.

  • Patent Advisor

    Martin H. Koo Ph.D.

    Hanyang Intl. Patent & Law Firm
    BKL Law Firm
    Ph.D, Yonsei University

Partners & Customers

  • partner01.jpg
  • partner02.jpg
  • partner03.jpg
  • partner04.jpg
  • partner05.jpg
  • partner06.jpg
  • partner07.jpg
  • partner08.jpg
  • partner09.jpg
  • partner10.jpg
  • partner11.jpg
  • partner12.jpg
  • partner13.jpg
  • partner14.jpg
  • partner15.jpg
  • partner16.jpg
  • partner17.jpg
  • partner18.jpg
  • partner19.jpg
  • partner20.jpg
  • partner21.jpg
  • partner22.jpg
  • partner23.jpg
  • partner24.jpg
  • partner25.jpg
  • partner26.jpg
  • partner27.jpg
  • partner28.jpg